James Hamilton

Chief of Discovery & Translational Medicine at Arrowhead Pharmaceuticals

Speaker

Dr. James Hamilton currently serves as Vice President Clinical Development at Arrowhead Pharmaceuticals where he is responsible for clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520, ARC-521 and ARC-AAT global programs through mid-stage development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led Arrowhead’s acquisition of the Novartis RNAi assets and led Arrowhead’s $670 Million cardiovascular deal with Amgen. Dr. Hamilton previously served as CEO of Calando Pharmaceuticals. He earned an MD and MBA at The Ohio State University and is board certified in Emergency Medicine.